🇨🇦 PF-08065010 in Canada

PF-08065010 (pf-08065010) regulatory status in Canada.

Marketing authorisation

PF-08065010 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is PF-08065010 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for PF-08065010 in Canada?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.